Author

Efrosini Lyraraki

Observed names: E Lyraraki, E. Lyraraki

Observed institutions: University of Crete, University Hospital of Heraklion

OpenAlex ID: A5110030182

Scattered dose to radiosensitive organs and associated risk for cancer development from head and neck radiotherapy in pediatric patients

2012 · Kalliopi M. Kourinou, Michalis Mazonakis, et al. · Physica Medica · 41

Risk of contralateral breast and ipsilateral lung cancer induction from forward-planned IMRT for breast carcinoma

2019 · M. Mazonakis, J. Stratakis, et al. · Physica Medica · 17

A phase I trial of weekly docetaxel and cisplatinum combined to concurrent hyperfractionated radiotherapy for non-small cell lung cancer and squamous cell carcinoma of head and neck

2003 · H. Varveris, M. Mazonakis, et al. · Oncology Reports · 16

Probability of carcinogenesis due to involved field and involved site radiation therapy techniques for supra- and infradiaphragmatic Hodgkin’s disease

2019 · Kalliopi M. Kourinou, Michalis Mazonakis, et al. · Physica Medica · 10

Thyroid exposure to scattered radiation and associated second cancer risk from paediatric radiotherapyfor extracranial tumours

2012 · M. Mazonakis, K. Kourinou, et al. · Radiation Protection Dosimetry · 10

Pegulated liposomal doxorubicin and cisplatin given concurrently with conventional radiotherapy: A phase I dose-escalation trial for patients with squamous cell carcinoma of head and neck and lung

2004 · H. Varveris, S. Kachris, et al. · Oncology Reports · 9

Phase I/II study of gemcitabine combined with cisplatin weekly and concurrent thoracic MV-radiotherapy for patients with stage IIIA/B non small cell lung cancer (NSCLC)

2000 · Ch Varveris, E Lyraraki, et al. · Lung Cancer · 8

Peripheral primitive neuroectodermal tumour during pregnancy

2002 · H Varveris, M Mazonakis, et al. · British Journal of Radiology · 7

Lifetime radiation-induced sarcoma risk in patients subjected to IMRT or VMAT for uterine cervix carcinoma

2021 · M. Mazonakis, E. Lyraraki, et al. · Physical and Engineering Sciences in Medicine · 5

Radiotherapy for non-malignant shoulder syndrome: Is there a risk for radiation-induced carcinogenesis?

2017 · M. Mazonakis, E. Lyraraki, et al. · Physica Medica · 5

Radiotherapy for breast cancer with the field-in-field technique: assessment of the probability for developing a secondary malignancy in the contralateral breast using linear and non-linear models

2021 · M. Mazonakis, J. Stratakis, et al. · Physica Medica

Lung and breast cancer risk estimates following involved-site radiation therapy for supradiaphragmatic Hodgkin's disease in female patients

2017 · Michalis Mazonakis, John Damilakis, et al. · Journal of Medical Physics

Radiation dose to adjacent organs-at-risk from involved-field and involved-site radiotherapy for lymphoma

2017 · Mazonakis, John Damilakis, et al. · Journal of Medical Physics

5032 POSTER Phase I/II trial of external irradiation plus medium-dose brachytherapy given concurrently to liposomal doxorubicin and cisplatin for advanced uterine cervix cancer

2007 · E. Petinellis, M. Mazonakis, et al. · European Journal of Cancer Supplements

Phase I trial of weekly docetaxel and cisplatin combined to concurrent external hyperfractionated irradiation in the treatment of locally advanced squamous cell carcinoma of head and neck

2007 · E. Lyraraki, H. Varveris, et al. · Radiotherapy and Oncology

Concurrent platinum and docetaxel chemotherapy and concomitant boost external radiotherapy for patients with invasive transitional cell bladder carcinoma (TCBC)

1999 · H. Varveris, M. Mazonakis, et al. · European Journal of Cancer

Concurrent radiotherapy and chemotherapy with topotecan and stealth liposomal doxorubicin for the treatment of locally advanced pelvic tumours

1999 · M.I. Koukourakis, D. Chaldeopoulos, et al. · European Journal of Cancer

Works count: 17

Citation count: 128

H-index: 7

I10-index: 5